Oklo (NYSE:OKLO) provided investors an update on its strategic progress along with its Q2 financial results, targeting commercial operations between 2027 and early 2028.
The pre-revenue nuclear energy company reported a net loss of $28 million for the quarter. This was up from a loss of $17.7 million in Q2 2024, in part driven by $11.4 million in non-cash stock-based compensation expenses.
Its loss per share was $0.18, up from a loss per share of $0.27 in the year-ago quarter and higher than analyst estimates of a loss per share of $0.11.
Regulatory progress during Q2 included the completion of Phase I of the Nuclear Regulatory Commission readiness assessment with no major findings and plans to submit their Combined License Application (COLA) by Q4 2025.
The company also expanded its commercial partnerships with the US military, Liberty Energy, Vertiv, and Korea Hydro & Nuclear Power.
Wedbush welcomed the “solid” results, maintaining their ‘Outperform’ rating and increasing their price target to $80 from $75.
“Oklo continues to stand out within the rapidly developing nuclear industry from competition with its attractive build, own, and operate business model, which in turn will provide long-term recurring revenues and a more streamlined regulatory,” they wrote.
They expect the company to benefit from several Federal tailwinds, including an Executive Order (EO) signed by President Trump directing accelerated nuclear deployment in a much more streamlined process.
“The massive EO was followed by the recently signed One Big Beautiful Bill and America's AI Action Plan representing significant tailwinds for the US nuclear industry with OKLO being one of the main beneficiaries as US government support for nuclear energy has gained significant traction since the Trump Administration took over in January as the company has key allies in the White House,” they wrote.
Shares of Oklo traded up 1.7% at about $73 on Tuesday morning.